Virtual Lecture
The Continuum of Care in Psoriatic Disease: Expanding Treatment Options, Individualizing Management
Release Date: March 31, 2022
Expiration Date: March 30, 2023
CE/CME Credit Hours: 1.00
Pharmacology Credit Hours: 1.00
Begin »
Program Overview
Program Description
Psoriatic disease, encompassing both psoriasis and psoriatic arthritis, carries a significant burden for a patient’s mental and physical quality of life. Patients can become distressed by the discomfort caused by psoriasis plaques, as well as embarrassed by their appearance—especially if they occur in prominent areas, such as the scalp. Further, up to 30% of people with psoriasis will go on to develop psoriatic arthritis. Optimal management must take into account individual patient factors, comorbidities, and the range of available therapeutics. In this video lecture, an expert explores the steps for management of psoriatic disease—from classifying disease severity, to the plethora of considerations for treatment selection, to long-term management of the disease and associated comorbidities.
Format
Interactive video lecture
Learning Objectives
After completing this activity, participants should be better able to:
- Identify drug classes used in treatment of psoriatic disease, their recommended use, and potential adverse events
- Summarize strategies for individualized management of patients with psoriatic disease and comorbidities
- Implement management practices to address long-term follow-up and management of patients with psoriatic disease
Target Audience
NPs and PAs
Faculty
Veronica Richardson, MSN, ANP-BC, DCNP
- Nurse Practitioner
- Department of Medical Dermatology
- Perelman Center for Advanced Medicine
- University of Pennsylvania
- Philadelphia, Pennsylvania
Susan Tiso, DNP, FNP-BC
- Consultant; Retired Clinical Professor
- Family Nurse Practitioner
- Department of Family Medicine
- Sue & Bill Gross School of Nursing
- University of California, Irvine
- Irvine, California
Details
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until March 30, 2023. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Tracey M. Piparo, PA-C, RJW Barnabas Health, New Brunswick, New Jersey
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program is cosupported by educational grants from Alcon Vision, LLC; Biohaven Pharmaceuticals; Genentech, a member of the Roche Group; Gilead Sciences, Inc.; and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Ms Richardson: consulting fees: Boehringer Ingelheim, Lilly.
Dr Tiso has no relevant financial relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the evaluation form
The estimated time to complete this activity is 1.00 hour.
Release date: March 31, 2022
Expiration date: March 30, 2023
For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 102321C-7C